Kurata, Hideaki
Meguro, Shu
Abe, Yukiko
Sasaki, Takashi
Asakura, Keiko
Arai, Yasumichi
Itoh, Hiroshi
Funding for this research was provided by:
Daiichi Sankyo Co, Ltd.
Article History
Received: 5 April 2023
Accepted: 15 July 2023
First Online: 9 August 2023
Declarations
:
: We have complied with all relevant regulations and guidelines for work with humans. The KAWP study was approved by the ethics committee of the Keio University School of Medicine (ID: 20160297) and was registered in the University Hospital Medical Information Network Clinical Trial Registry as an observational study (ID: UMIN000026053). Written informed consent to participate in the study KAWP was obtained from all participants.
: Not applicable.
: SM reports honoraria from Abbott Japan Co. Ltd, Asahi Kasei Pharma Co., AstraZeneca K.K., Daiichi Sankyo Co., Ltd., Eisai Co., Ltd., li Lilly Japan K.K., Kaken Pharmaceutical Co., Ltd., Kowa Company, Ltd., Kyowa Hakko Kirin Co. Ltd., Life Scan Japan Inc., Mitsubishi Tanabe Pharma Corporation, Mochida Pharmaceutical Co. Ltd., MSD K.K., Nippon Boehringer Ingelheim Co. Ltd., Nipro Corporation, Novo Nordisk Pharma Ltd., Ono Pharmaceutical Co. Ltd., Sanofi K.K., Sanwa Kagaku Kenkyusho Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd., Teijin Pharma Ltd., outside the submitted work.HI reports honoraria from Abbott Japan Co. Ltd., Astellas Pharma Inc., Chugai Pharmaceutical Co., Ltd., Daiichi Sankyo Co., Ltd., Kao Corporation., Kyowa Kirin Co., Ltd., LifeScan Japan K.K., Meiji Holdings Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Mochida Pharmaceutical Co., Ltd., MSD K.K., Nippon Boehringer Ingelheim Co. Ltd., Nipro Co., Ltd., Noster Inc., Novartis Pharma K.K., Oriental Yeast Co., Ltd., Ono Pharmaceutical Co. Ltd., SBI Pharmaceuticals Co., Ltd., Shionogi & Co., Ltd., Sumitomo Dainippon Pharma Co. Ltd., Takeda Pharmaceutical Co.,Ltd., Teijin Pharma Ltd., Wakunaga Pharmaceutical Co., Ltd., outside the submitted work. HI reports honoraria from Abbott Japan Co. Ltd., Astellas Pharma Inc., Chugai Pharmaceutical Co., Ltd., Daiichi Sankyo Co., Ltd., Kao Corporation., Kyowa Kirin Co., Ltd., LifeScan Japan K.K., Meiji Holdings Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Mochida Pharmaceutical Co., Ltd., MSD K.K., Nippon Boehringer Ingelheim Co. Ltd., Nipro Co., Ltd., Noster Inc., Novartis Pharma K.K., Oriental Yeast Co., Ltd., Ono Pharmaceutical Co. Ltd., SBI Pharmaceuticals Co., Ltd., Shionogi & Co., Ltd., Sumitomo Dainippon Pharma Co. Ltd., Takeda Pharmaceutical Co., Ltd., Teijin Pharma Ltd., Wakunaga Pharmaceutical Co., Ltd., outside the submitted work.